 Comparison effects thrombolytic therapy left ventricular function patients years age study effect age left ventricular LV function contrast ventriculography weeks first acute myocardial infarction patients thrombolytic therapy hours onset infarction patients placebo Streptokinase patients recombinant tissue-type plasminogen activator rt-PA Patients age groups years equal years Thrombolytic therapy ejection fraction age groups group group Ejection fraction identical streptokinase- rt-PA-treated patients Multifactor analysis variance age thrombolytic therapy improved ejection fraction Thrombolytic therapy end-systolic volume ml elderly ml group Minor complications frequent elderly serious hemorrhages patients equal years findings thrombolysis LV function age groups age ejection fraction acute myocardial infarction thrombolytic therapy benefits patients